BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28573581)

  • 21. De novo calcium/sulfur SAD phasing of the human formylglycine-generating enzyme using in-house data.
    Roeser D; Dickmanns A; Gasow K; Rudolph MG
    Acta Crystallogr D Biol Crystallogr; 2005 Aug; 61(Pt 8):1057-66. PubMed ID: 16041070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of phasing methods for sulfur-SAD using in-house chromium radiation: case studies for standard proteins and a 69 kDa protein.
    Watanabe N; Kitago Y; Tanaka I; Wang Jw; Gu Yx; Zheng Cd; Fan Hf
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1533-40. PubMed ID: 16239732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of sulfur SAD to small crystals with a large asymmetric unit and anomalous substructure.
    Mou TC; Zeng B; Doukov TI; Sprang SR
    Acta Crystallogr D Struct Biol; 2022 Aug; 78(Pt 8):1021-1031. PubMed ID: 35916226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the combination of molecular replacement and single-wavelength anomalous diffraction phasing for automated structure determination.
    Panjikar S; Parthasarathy V; Lamzin VS; Weiss MS; Tucker PA
    Acta Crystallogr D Biol Crystallogr; 2009 Oct; 65(Pt 10):1089-97. PubMed ID: 19770506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy among phase-refinement techniques in macromolecular crystallography.
    Burla MC; Cascarano GL; Giacovazzo C; Polidori G
    Acta Crystallogr D Struct Biol; 2017 Nov; 73(Pt 11):877-888. PubMed ID: 29095160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystallization and calcium/sulfur SAD phasing of the human EF-hand protein S100A2.
    Koch M; Diez J; Wagner A; Fritz G
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Sep; 66(Pt 9):1032-6. PubMed ID: 20823519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phasing on anomalous signal of sulfurs: what is the limit?
    Ramagopal UA; Dauter M; Dauter Z
    Acta Crystallogr D Biol Crystallogr; 2003 Jun; 59(Pt 6):1020-7. PubMed ID: 12777765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRSAD: using anomalous dispersion from S atoms collected at Cu Kalpha wavelength in molecular-replacement structure determination.
    Schuermann JP; Tanner JJ
    Acta Crystallogr D Biol Crystallogr; 2003 Oct; 59(Pt 10):1731-6. PubMed ID: 14501111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substructure solution with SHELXD.
    Schneider TR; Sheldrick GM
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1772-9. PubMed ID: 12351820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can I solve my structure by SAD phasing? Planning an experiment, scaling data and evaluating the useful anomalous correlation and anomalous signal.
    Terwilliger TC; Bunkóczi G; Hung LW; Zwart PH; Smith JL; Akey DL; Adams PD
    Acta Crystallogr D Struct Biol; 2016 Mar; 72(Pt 3):359-74. PubMed ID: 26960123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving experimental phasing: the role of strongest reflections.
    Vekhter Y
    Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):899-902. PubMed ID: 15983412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography.
    Mehr A; Henneberg F; Chari A; Görlich D; Huyton T
    Acta Crystallogr D Struct Biol; 2020 Dec; 76(Pt 12):1222-1232. PubMed ID: 33263328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated structure solution, density modification and model building.
    Terwilliger TC
    Acta Crystallogr D Biol Crystallogr; 2002 Nov; 58(Pt 11):1937-40. PubMed ID: 12393925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced site-specific damage of mercury derivatives: phasing and implications.
    Ramagopal UA; Dauter Z; Thirumuruhan R; Fedorov E; Almo SC
    Acta Crystallogr D Biol Crystallogr; 2005 Sep; 61(Pt 9):1289-98. PubMed ID: 16131763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the error term in direct-method SAD phasing.
    Wang JW; Chen JR; Gu YX; Zheng CD; Jiang F; Fan HF
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1987-90. PubMed ID: 15502306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anomalous signal of solvent bromides used for phasing of lysozyme.
    Dauter Z; Dauter M
    J Mol Biol; 1999 May; 289(1):93-101. PubMed ID: 10339408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phasing via SAD/MAD data: the method of the joint probability distribution functions.
    Giacovazzo C; Siliqi D
    Acta Crystallogr D Biol Crystallogr; 2004 Jan; 60(Pt 1):73-82. PubMed ID: 14684895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extending the novel |ρ|-based phasing algorithm to the solution of anomalous scattering substructures from SAD data of protein crystals.
    Rius J; Torrelles X
    Acta Crystallogr A Found Adv; 2022 Nov; 78(Pt 6):473-481. PubMed ID: 36318068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced Crystallographic Data Collection Protocols for Experimental Phasing.
    Finke AD; Panepucci E; Vonrhein C; Wang M; Bricogne G; Oliéric V
    Methods Mol Biol; 2016; 1320():175-91. PubMed ID: 26227043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extending molecular-replacement solutions with SHELXE.
    Thorn A; Sheldrick GM
    Acta Crystallogr D Biol Crystallogr; 2013 Nov; 69(Pt 11):2251-6. PubMed ID: 24189237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.